DOI: https://doi.org/10.14739/2310-1210.2014.3.26054

Взаимосвязь хронической обструктивной болезни легких и ишемической болезни сердца: вопросы патогенеза и стратегия лечения

O. V. Yatsenko

Аннотация


Углубляется понимание коморбидного течения хронического обструктивного заболевания легких и ишемической болезни сердца, его клинических проявлений, но в международных и национальных клинических рекомендациях и терапевтических руководствах этому вопросу уделено недостаточно внимания. С целью описания распространенности хронического обструктивного заболевания легких и ишемической болезни сердца, факторов риска, возможных патогенетических механизмов, основных симптомов и терапевтических стратегий лечения провели обзор специализированной литературы. Проанализировали распространенность объединения этих заболеваний, что свидетельствует о важности для клинициста своевременной диагностики для улучшения фармакотерапевтического подхода, индивидуализации тактики ведения больного и снижения уровня смертности. Описали патогенетическую взаимосвязь хронического обструктивного заболевания легких и ишемической болезни сердца. Установили, что клинические проявления этих заболеваний похожи, имеют общие симптомы, приводя к их недооценке, а значит и к гиподиагностике сопутствующих заболеваний. 


Ключевые слова


ишемическая болезнь сердца; хроническая обструктивная болезнь легких

Полный текст:

PDF

Литература


Global initiative for chronic obstructive lung disease global strategy for diagnosis, management, and prevention of COPD Updated Feb 2013. Available from: http://www.goldcopd.org/Guidelines/guidelines-resources.

Schnell, K., Weiss, C. O., Lee, T., Krishnan, J. A., Leff, B., Wolff, J. L., et al. (2012). The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulmonary Medicine, 12(1), 26. doi:10.1186/1471-2466-12-26.

Müllerova, H., Agusti, A., Erqou, S., & Mapel, D. W. (2013) Cardiovascular comorbidity in chronic obstructive pulmonary disease: systematic literature review. Chest, 144(4), 1163–1178.

Eriksson, B., Lindberg, A., Müllerova, H., Rönmark, E., & Lundbäck, B. (2013). Association of heart diseases with COPD and restrictive lung function – Results from a population survey. Respiratory Medicine, 107(1), 98–106. doi: 10.1016/j.rmed.2012.09.011.

Reed, R. M., Eberlein, M., Girgis, R. E., Hashmi, S., Iacono, A., Jones, S., et al. (2012). Coronary Artery Disease Is Under-diagnosed and Under-treated in Advanced Lung Disease. The American Journal of Medicine, 125(12), 1228. doi: 10.1016/j.amjmed.2012.05.018.

Formiga, F., Ferrer, A., Sanz, H., Marengoni, A., Alburquerque, J., & Pujol, R. (2013). Patterns of comorbidity and multimorbidity in the oldest old: The Octabaix study. European Journal of Internal Medicine, 24(1), 40–44. doi: 10.1016/j.ejim.2012.11.003.

Patel, A. R., Donaldson, G. C., Mackay, A. J., Wedzicha, J. A., & Hurst, J. R. (2012) The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest, 141(4), 851–857. doi: 10.1378/chest.11-0853.

Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., et al. (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet, 370, 741–50.

Waatevik, M., Skorge, T. D., Omenaas, E., Bakke, P. S., Gulsvik, A., & Johannessen, A. (2013). Increased prevalence of chronic obstructive pulmonary disease in a general population. Respiratory Medicine, 107(7), 1037–1045. doi: 10.1016/j.rmed.2013.04.008.

Fact sheet № 317 / WHO, Media, centre. – 2013.

Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E.,J., Berry, J. D., & Borden, W. B. (2013) Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation, 127, e6–245. doi: 10.1161/CIR.0b013e31828124ad.

Koronatskyi, V. M. (2012) Sertsevo-sudynna zakhvoriuvannist v Ukraini ta recomendatsii shchodo pokrashchennia zdorovia v suchasnykh umovakh. [Cardiovascular morbidity in Ukraine and recommendations for improving health in modern conditions]. Kyiv. [in Ukrainian].

Arbab-Zadeh, A., Nakano, M., Virmani, R., & Fuster, V. (2012) Acute coronary events. Circulation, 125, 1147–1156. doi: 10.1161/CIRCULATIONAHA.111.047431.

Johnston, A. K., Mannino, D. M., Hagan, G. W., Davis, K. J., & Kiri, V. A. (2008). Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax, 63(7), 599–605. doi: 10.1136/thx.2007.088112.

Lange, P., Mogelvang, R., Marott, J. L., Vestbo, J., & Jensen, J. S. (2010). Cardiovascular Morbidity in COPD: A Study of the General Population. COPD: Journal of Chronic Obstructive Pulmonary Disease, 7(1), 5–10. doi: 10.3109/15412550903499506.

Nishiyama, K., Kita, T., Ozasa, N., Taniguchi, R., Ehara, N., Nakagawa, Y., et al. (2010). Chronic obstructive pulmonary disease–An independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease. International Journal of Cardiology, 143(2), 178–183.

Campo, G., Guastaroba, P., Marzocchi, A., Santarelli, A., Varani, E., & Vignali, L. (2013) Impact of COPD on long-term outcome after St-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. Chest, 144, 750–7. doi: 10.1378/chest.12-2313.

Divo, M., Hunninghake, G., Celli, B., Zagaceta, J., Cabrera, C., Zulueta, J., et al. (2012). Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 186(2), 155–161.

Mcallister, D. A., Macfarlane, P. W., Mills, N. L., Maclay, J. D., Macnee, W., Clark, E., et al. (2012). Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. European Respiratory Journal, 39(5), 1097–1103.

Sibila, O., Mortensen, E. M., Anzueto, A., Laserna, E., Restrepo, M. I. (2013) Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia. Eur Respir J, 43, 36–42. doi: 10.1183/09031936.00117312.

Donaldson, G. C., Hurst, J. R., Smith, C. J., Hubbard, R. B., & Wedzicha, J. A. (2010). Increased Risk Of Myocardial Infarction And Stroke Following Exacerbation Of COPD. Chest, 137(5), 1091–1097. doi: 10.1378/chest.09-2029.

Piera, B., Bianca, B., Fabbri, M., Claudio, C. (2012) Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice. Respirology, 17(3), 422–431. doi: 10.1111/j.1440-1843.2011.02118.x

Man, S. P., Eeden, S. V., & Sin, D. D. (2012). Vascular Risk in Chronic Obstructive Pulmonary Disease: Role of Inflammation and Other Mediators. Canadian journal of cardiology, 28(6), 653–661.

Kawut, S. M. (2013) COPD: CardiOPulmonary disease? Eur Respir J 2013, 41, 1241–3. doi:10.1183/09031936.00009413.

Maclay, J. D., & Macnee, W. (2013) Cardiovascular disease in COPD: mechanisms. Chest, 143, 798–807. doi: 10.1378/chest.12-0938.

Donald, B. (2005) Hunninghake "Cardiovascular Disease in Chronic Obstructive Pulmonary Disease". Proceedings of the American Thoracic Society, Vol. 2, Symposium: Chronic Obstructive Pulmonary Disease: a disorder of the cardiovascular and respiratory systems, 44–49.

Radak, D., Babic, S., Peric, M., Popov, P., Tanaskovic, S., Babic, D., et al. (2012) Distribution of risk factors in patients with premature coronary, supra-aortic branches and peripheral atherosclerotic disease. Med Princ Pract, 21, 228–233. doi:10.1159/000334617.

Jerrett, M., Burnett, R. T., Pope, C. A., Ito, K., Thurston, G., Krewski, D., et al. (2009). Long-Term Ozone Exposure and Mortality. New England Journal of Medicine, 360(11), 1085–1095. doi: 10.1056/NEJMoa0803894.

Corrales-Medina, V. F., Musher, D. M., Wells, G. A., Chirinos, J. A., Chen, L., & Fine, M. J. (2012). Cardiac Complications in Patients With Community-Acquired Pneumonia: Incidence, Timing, Risk Factors, and Association With Short-Term Mortality. Circulation, 125(6), 773–781. doi: 10.1161/CIRCULATIONAHA.111.040766.

Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G., & Wouters, E. F. (2007). Systemic Effects Of Smoking. Chest, 131(5), 1557–1566.

Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, W. M., et al. (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J, 33, 1635–1701.

Watz, H., Waschki, B., Kirsten, A., Muller, K., Kretschmar, G., Meyer, T., et al. (2009). The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD: Frequency and Associated Consequences for Systemic Inflammation and Physical Inactivity. Chest, 136(4), 1039–1046.

Kaptoge, S., DiAngelantonio, E., Pennells, L., Wood, A. M., White, I. R., & Gao P. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med, 367, 1310–1320. doi: 10.1056/NEJMoa1107477.

Decramer, M., Janssens, W., & Miravitlles, M. (2012) Chronic obstructive pulmonary disease. Lancet, 379, 1341–1351. doi: 10.1016/S0140-6736(11)60968-9.

Soriano, J. B., & Rodriguez-Roisin, R. (2011). Chronic Obstructive Pulmonary Disease Overview: Epidemiology, Risk Factors, And Clinical Presentation. Proceedings of the American Thoracic Society, 8(4), 363–367. doi: 10.1513/pats.201102-017RM.

Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 187, 347–65. doi: 10.1164/rccm.201204-0596PP.

Agustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., et al. (2012) Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE, 7, e37483. doi: 10.1371/journal.pone.0037483.

Bertoletti, L., Todoli, J. A., Barron, M., Valdes, M., Tolosa, C., Martin-Villasclaras, J. J., et al. (2012). Clinical presentation and outcome of venous thromboembolism in COPD. European Respiratory Journal, 39(4), 862–868. doi:10.1183/09031936.00058811.

Lee, H., & Oh, B. (2010). Aging and Arterial Stiffness. Circulation Journal, 74(11), 2257–2262.

Vanfleteren L.E, Spruit M.A., Groenen M., Gaffron S., van Empel V.P., Bruijnzeel P.L., Rutten, E. P., Op 't Roodt, J., Wouters, E. F., & Franssen, F. M. (2013) Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 187, 728–35. doi: 10.1164/rccm.201209-1665OC.

Roca, M., Verduri, A., Corbetta, L., Clini, E., Fabbri, L. M., & Beghé, B. (2013). Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease. European Journal of Clinical Investigation, 43(5), 510–521. doi: 10.1111/eci.12064.

García-Olmos, L., Alberquilla, A., Ayala, V., García-Sagredo, P., Morales, L., & Carmona, M. (2013) Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract, 14, 11. doi:10.1186/1471-2296-14-11.

Fihn, D. S. & Gardin, M. J. (2012) 2012 AHA/ACCF Guideline for the management stable ischemic heart disease. Journal of the American College of Cardiology, 60(24). doi:10.1016/j.jacc.2012.07.012.

(2013) MOH of Ukraine on 27 June 2013 № 555. Retrieved from http://www.moz.gov.ua/ua/portal/dn_20130627_0555.html.

Matera, M. G., Calzetta, L., Rinaldi, B., & Cazzola, M. (2012). Treatment of COPD: moving beyond the lungs. Current Opinion in Pharmacology, 12(3), 315–322. doi: 10.1016/j.coph.2012.04.001.

Calverley, P. M., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., et al. (2010) Cardiovascular events in patients with COPD: TORCH study results. Thorax, 65, 719–725. doi: 10.1136/thx.2010.136077.

Etminan, M., Jafari, S., Carleton, B., & Fitzgerald, J. (2012). Beta-blocker use and COPD mortality: a systematic review and meta-analysis. BMC Pulmonary Medicine, 12(1), 48. doi:10.1186/1471-2466-12-48.

Ekström, M. P., Hermansson, A. B., & Ström, K. E. (2013). Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 187(7), 715–720. doi: 10.1164/rccm.201208-1565OC.

(2003) Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5,953 people with diabetes: a randomized placebo-controlled trial. Lancet, 361, 2005–2016.


Ссылки

  • На текущий момент ссылки отсутствуют.


Запорожский медицинский журнал   Лицензия Creative Commons
Запорожский государственный медицинский университет